North South Ventures is a cross-border venture capital fund that invests in early stage med companies. We are co-located in academic med superclusters (Stanford/UCSF, University of Toronto); we have proprietary deal flow from top US and Canadian academic centres. As a team, we have invested in over 350 medical portfolio companies and 40+ FDA approvals in the biotech, med device, and digital health/ AI spaces with $4B+ in cumulative funding and three multi billion dollar IPOs since 2012.